Health-related quality-of-life improvements during 98 weeks of infliximab therapy in patients with plaque-type psoriasis in real-world practice

We evaluated the effect of plaque-type psoriasis on health-related quality of life (HRQoL) of patients who received infliximab (IFX) in real-world clinical settings.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Shear, Neil H. (VerfasserIn) , Hartmann, Martin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 11 February 2016
In: Quality of life research
Year: 2016, Jahrgang: 25, Heft: 8, Pages: 2031-2040
ISSN:1573-2649
DOI:10.1007/s11136-015-1224-z
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s11136-015-1224-z
Volltext
Verfasserangaben:N.H. Shear, M. Hartmann, M.E. Toledo-Bahena, M. Gilbert, A. Katsambas, R. Yao, Z. Popmihajlov
Beschreibung
Zusammenfassung:We evaluated the effect of plaque-type psoriasis on health-related quality of life (HRQoL) of patients who received infliximab (IFX) in real-world clinical settings.
Beschreibung:Gesehen am 06.05.2020
Beschreibung:Online Resource
ISSN:1573-2649
DOI:10.1007/s11136-015-1224-z